AP
Atea Pharmaceuticals Inc
🇺🇸XNAS.AVIRUnited StatesHealthcare
$5.21USDdown -0.02 (-0.38%)OpenDelayed5:09 PM
Price$5.21-0.02 (-0.38%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US04683R1068
- CUSIP
- 04683R106
Company
- Employees
- 55
- Headquarters
- Boston, United States
- Website
- https://ateapharma.com
- CEO
- Dr. Jean-Pierre Sommadossi Ph.D.
Market
- Shares outstanding
- 80.2M
- Market cap
- $417.87M
Highlights
- Market cap
- $416.26M
- EPS LTM
- -$2.06
- P/E LTM
- -2.22
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$165.29M-21.42%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$152.07M-30.13%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.